Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
The American Journal of Psychiatry|January 5, 2002
Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naive T cells (CD4(+)CD45RA(+)CD29(+))Michael H Antoni, Dean G Cruess, Nancy Klimas, et al.Journal of Psychosomatic Research|March 18, 2005
Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected menMichael H Antoni, Dean G Cruess, Nancy Klimas, et al.International Journal of Behavioral Medicine|May 9, 2009
Depressive symptoms and cervical neoplasia in HIV+ low-income minority women with human papillomavirus infectionStacy M Dodd, Deidre B Pereira, Ilona Marion, et al.Stem Cell Reports|September 26, 2014
Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cellsDoan C Nguyen, Tracy A Hookway, Qingling Wu, et al.Congenital Heart Disease|September 7, 2016
"Frontiers in Fontan failure: A summary of conference proceedings"Camden Hebson, Wendy Book, Robert W Elder, et al.Advances in Therapy|March 10, 2026
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyDavid Zisman, Sandeep Sahay, Debabrata Bandyopadhyay, et al.IEEE Journal of Translational Engineering in Health and Medicine|July 30, 2021
Opportunities for Regulatory Changes to Promote Pediatric Device Innovation in the United States: Joint Recommendations From Pediatric Innovator RoundtablesTerence Sanger, Anthony Chang, William Feaster, et al.Bioanalysis|December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)Surinder Kaur, Stephen C Alley, Matt Szapacs, et al.Pageof 6